mci-196 has been researched along with Renal Insufficiency, Chronic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Guo, H; Li, Y; Liu, H; Yang, X; Zhang, X | 1 |
| Dimkovic, N; Locatelli, F; Spasovski, G | 2 |
| Dellanna, F; Dimkovic, N; Locatelli, F; Pontoriero, G; Spasovski, G; Wanner, C | 1 |
| Apanasovich, N; Dosta, N; Locatelli, F; März, W; Varushchanka, A; Wanner, C; Yakubtsevich, R | 1 |
| Del Vecchio, L; Locatelli, F | 1 |
| Dimkovic, N; Hertel, J; Locatelli, F; Spasovski, G; Wanner, C | 1 |
| Dimkovic, N; Locatelli, F; Spasovski, G; Wanner, C | 1 |
3 review(s) available for mci-196 and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease.
Topics: Bile Acids and Salts; Calcium; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Iron; Iron Compounds; Niacin; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.
Topics: Bile Acids and Salts; Calcium; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate binders.
Topics: Animals; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Renal Insufficiency, Chronic; Sevelamer | 2015 |
5 trial(s) available for mci-196 and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial.
Topics: Bile Acids and Salts; Dose-Response Relationship, Drug; Double-Blind Method; Dyslipidemias; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2013 |
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Calcium; Cholesterol; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Young Adult | 2014 |
Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients.
Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Europe; Female; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Time Factors; Treatment Outcome; Triglycerides | 2014 |
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2015 |
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol, LDL; Diarrhea; Female; Glycated Hemoglobin; Hemodialysis Solutions; Humans; Hyperphosphatemia; Male; Middle Aged; Nausea; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Renal Dialysis; Renal Insufficiency, Chronic; Uric Acid; Vomiting | 2016 |